映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09606 映恩生物-B

已收盘 01-12 16:08:30

355.800

-5.200

-1.44%

最高370.800	最低348.200	成交量72.93万
今开366.000	昨收361.000	日振幅6.26%
总市值318.14亿	流通市值318.14亿	总股本8,942万
成交额2.59亿	换手率0.82%	流通股本8,942万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"映恩生物-B","latestPrice":355.8,"timestamp":1768205310007,"preClose":361,"halted":0,"volume":729340,"delay":0,"floatShares":89415400,"shares":89415400,"eps":-131.30424,"marketStatus":"已收盘","change":-5.2,"latestTime":"01-12 16:08:30","open":366,"high":370.8,"low":348.2,"amount":259448563,"amplitude":0.062604,"askPrice":355.8,"askSize":200,"bidPrice":355.6,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":-34.716,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":5,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":361,"openAndCloseTimeList":[[1768181400000,1768190400000],[1768194000000,1768204800000]],"volumeRatio":0.585362,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606","defaultTab":"news","newsList":[{"id":"2602659414","title":"【券商聚焦】海通国际：市场对2026年创新药产业链情绪偏积极 看好荣昌生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2602659414","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602659414?lang=zh_cn&edition=full","pubTime":"2026-01-12 15:45","pubTimestamp":1768203955,"startTime":"0","endTime":"0","summary":"金吾财讯 | 海通国际研报指出，上周恒生医疗保健指数上涨10.3%，跑赢恒生指数10.7个百分点。2026年年初以来，恒生医疗保健指数涨幅为12.4%，跑赢恒生指数10.0个百分点。该机构指出，上周部分细分板块龙头显著反弹，主要归因于：一方面，前期获利了结资金影响逐步出清；另一方面，市场对2026年创新药产业链情绪偏积极，看好管线优质和推进速度快、有BD潜力、股价位置合理的板块龙头，如荣昌生物、映恩生物等。同时，受到AI主题热度高涨影响，AI医疗概念走强，高增速、业绩兑现度高的主题标的医脉通、平安好医生涨幅明显。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973039","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1615","BK0239","06978","LU1969619763.USD","LU1064131003.USD","LU1046422090.SGD","BK1587","LU1235295612.USD","BK1571","BK1617","BK1583","09995","LU2543165471.USD","HK0000252160.HKD","01833","LU2148510915.USD","09606","159992","02192","BK1142","LU2488822045.USD","BK1515","LU0049112450.USD","BK1189","LU1064130708.USD","BK1161","HK0000252152.HKD","BK1219","HK0000500386.USD","LU2328871848.SGD","BK1247","688331"],"gpt_icon":0},{"id":"2601296362","title":"每日卖空追踪 | 映恩生物-B 01月08日卖空量成交1.78万股，卖空比例为1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601296362","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601296362?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861042,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月08日，涨1.55%，卖空量成交1.78万股，较上一交易日减少53.28%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108165137a4ab4936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108165137a4ab4936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","09606","HK0000252160.HKD","BK1161"],"gpt_icon":0},{"id":"2601362756","title":"映恩生物-B01月08日获主力加仓9013.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601362756?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:16","pubTimestamp":1767860163,"startTime":"0","endTime":"0","summary":"01月08日, 映恩生物-B股价涨1.55%，报收354.00元，成交金额6.0亿元，换手率1.86%，振幅7.97%，量比1.91。映恩生物-B今日主力资金净流入9013.7万元，连续5日净流入，上一交易日主力净流入4087.9万元。该股近5个交易日上涨17.51%，主力资金累计净流入1.9亿元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入9809.7万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162829a7022a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162829a7022a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000500386.USD","LU2543165471.USD","BK1161","HK0000252152.HKD","HK0000252160.HKD"],"gpt_icon":0},{"id":"1149091209","title":"映恩生物（09606）发布2025年12月股份变动月报，已发行股份增至89,415,414股","url":"https://stock-news.laohu8.com/highlight/detail?id=1149091209","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149091209?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:30","pubTimestamp":1767778255,"startTime":"0","endTime":"0","summary":"映恩生物于2026年1月7日提交截至2025年12月31日止的月度股份变动报告。公告显示，公司于本月底已发行股份总数由上月的88,879,214股增至89,415,414股，增加536,200股。公司表示，本次新增股份主要来自“首次公开发售前股权激励计划”的期权行使，合计带来2,848,890.62港元的资金收入。同时，报告期内无股份回购、赎回或库存股份变动及转换。公司称其本次所有操作已获董事会正式授权，遵循香港联交所《上市规则》及相关法律规定。本次公告由联席公司秘书袁佳丽签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"gpt_icon":0},{"id":"2601680148","title":"【券商聚焦】国泰海通证券上调映恩生物-B(9606)目标价至455.56港元 指ADC管线进展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2601680148","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601680148?lang=zh_cn&edition=full","pubTime":"2026-01-06 10:42","pubTimestamp":1767667374,"startTime":"0","endTime":"0","summary":"金吾财讯|国泰海通证券发布研报指，基于映恩生物-B在研ADC管线2025年的积极进展，上调目标价至455.56港元，维持\"增持\"评级。关键数据：当前股价296.40港元，52周区间176.50-510.00港元，市值263.44亿港元。上调HER2 ADC全球销售峰值至20亿美元，B7H3 ADC至26亿美元。主要风险为研发进展不及预期及行业政策风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106110941a4a160d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106110941a4a160d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","02611"],"gpt_icon":0},{"id":"2601834130","title":"2025年FDA批准44款新药 超半数为首创机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2601834130","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601834130?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:44","pubTimestamp":1767602642,"startTime":"0","endTime":"0","summary":"2025年FDA批准44款新药，超半数为“first-in-class”药物，标志着新药研发进入机制驱动时代。FDA药物评价与研究中心全年批准的新药中，创新机制药物占比过半，凸显治疗范式从“改良”向“颠覆”转变的趋势。多肽与核酸疗法在2025年取得重要突破，RNA靶向治疗进入收获期。2025年新药批准格局反映创新贯穿靶点发现、机制设计、递送系统与患者体验全链条，FDA对“first-in-class”药物的高比例批准，既响应科学进步，也体现对未满足临床需求的积极回应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105164616a49e353f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105164616a49e353f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000252152.HKD","BK1161","LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2601888804","title":"每日卖空追踪 | 映恩生物-B 01月05日卖空量成交5.41万股，卖空比例为4.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601888804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601888804?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601840,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间01月05日，涨11.81%，卖空量成交5.41万股，较上一交易日增加64.94%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163746a49e2bfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163746a49e2bfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","BK1161","HK0000500386.USD"],"gpt_icon":0},{"id":"2601888825","title":"映恩生物-B01月05日获主力加仓5518.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601888825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601888825?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:16","pubTimestamp":1767600962,"startTime":"0","endTime":"0","summary":"01月05日, 映恩生物-B股价涨11.81%，报收331.40元，成交金额3.7亿元，换手率1.28%，振幅13.70%，量比1.98。映恩生物-B今日主力资金净流入5518.7万元，上一交易日主力净流入115.8万元。该股近5个交易日上涨5.88%，主力资金累计净流入1818.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出2382.7万元，其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162321a49e1a7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162321a49e1a7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","BK1161","HK0000500386.USD","LU2543165471.USD","HK0000252152.HKD","09606"],"gpt_icon":0},{"id":"2601005560","title":"港股映恩生物-B涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601005560","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601005560?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:16","pubTimestamp":1767597360,"startTime":"0","endTime":"0","summary":"每经AI快讯，映恩生物-B(09606.HK)涨超12%，截至发稿涨12.08%，报332.2港元，成交额3.21亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608743450.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608743450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD","LU2543165471.USD","09606"],"gpt_icon":0},{"id":"2601003911","title":"港股异动 | 映恩生物-B(09606)涨超12% 2026年催化剂丰富 机构上调公司目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2601003911","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601003911?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:00","pubTimestamp":1767596406,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B涨超12%，截至发稿，涨12.08%，报332.2港元，成交额3.21亿港元。该行表示，基于映恩生物旗下管线在2025年极其顺利的进展情况，提高了HER2 ADCDB1303、B7H3 ADCDB1311，和HER3 ADCDB1310的潜在全球销售峰值预期。利用DCF估值法，该行上调映恩生物目标价至455.56港币，维持增持评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09606"],"gpt_icon":0},{"id":"2601075885","title":"国泰海通：上调映恩生物-B(09606)目标价至455.56港元 维持增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601075885","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601075885?lang=zh_cn&edition=full","pubTime":"2026-01-05 09:14","pubTimestamp":1767575675,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国泰海通发布研报称，基于映恩生物-B旗下管线在2025年极其顺利的进展情况，提高了HER2ADC DB1303、B7H3ADC DB1311，和HER3ADC DB1310的潜在全球销售峰值预期。利用DCF估值法，该行上调映恩生物目标价至455.56港币，维持增持评级。考虑到BNTX&映恩生物全球临床进展最快、数据量最丰富，该行看好两者的下一代肿瘤标准治疗竞争中的潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388438.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02611","09606"],"gpt_icon":0},{"id":"2600043255","title":"2025年医药IPO市场回暖，20余家药企成功上市募资","url":"https://stock-news.laohu8.com/highlight/detail?id=2600043255","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600043255?lang=zh_cn&edition=full","pubTime":"2026-01-04 10:33","pubTimestamp":1767493992,"startTime":"0","endTime":"0","summary":"回顾刚刚过去的2025年，生物医药企业IPO活动回升，根据数据统计，2025年全年共有21家生物药企成功实现IPO。其中，药企上演赴港IPO狂欢，累计有18家公司在港交所上市，募资总额约235亿港元。港股生物医药板块于2025年迎来强力反弹，18家药企IPO。而2022年板块21家新上市企业全部破发；2023年IPO数量仅10家，募资总额约107亿港元。据悉，2025年恒瑞医药单笔募资113亿港元，创下板块IPO纪录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104103529a6f041a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104103529a6f041a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","01276","02315","LU2543165471.USD","09606","BK1574","HK0000252152.HKD","BK1161","HK0000252160.HKD","HK0000500386.USD","BK1515"],"gpt_icon":0},{"id":"2600706433","title":"映恩生物-B12月31日主力净流入346.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2600706433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600706433?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:15","pubTimestamp":1767168939,"startTime":"0","endTime":"0","summary":"12月31日, 映恩生物-B股价涨0.40%，报收298.20元，成交金额1.1亿元，换手率0.40%，振幅4.38%，量比0.60。映恩生物-B今日主力资金净流入346.4万元，上一交易日主力净流出1160.9万元。该股近5个交易日下跌9.75%，主力资金累计净流出5097.9万元；近20日主力资金累计净流出6821.0万元，其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231161856a48db528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231161856a48db528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000500386.USD","09606","HK0000252152.HKD","BK1161","HK0000252160.HKD","LU2543165471.USD"],"gpt_icon":0},{"id":"2595743907","title":"每日卖空追踪 | 映恩生物-B 12月30日卖空量成交4.11万股，卖空比例为7.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595743907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595743907?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083440,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月30日，跌0.8%，卖空量成交4.11万股，较上一交易日减少15.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163638a6e07fe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163638a6e07fe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09606","HK0000500386.USD","LU2543165471.USD","BK1161","HK0000252152.HKD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2595679829","title":"映恩生物-B涨1.00% 股价突破300港元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2595679829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595679829?lang=zh_cn&edition=full","pubTime":"2025-12-30 09:30","pubTimestamp":1767058250,"startTime":"0","endTime":"0","summary":"2025年12月30日早盘09时30分，映恩生物-B股票出现异动，股价急速拉升1.00%。截至发稿，该股报302.400港元/股，成交量420股，换手率0.00%，振幅0.00%。资金方面，该股资金流入12.096万港元，流出0港元。机构评级方面，在所有6家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。映恩生物-B股票所在的生物技术行业中，整体跌幅为0.21%。映恩生物-B公司简介：映恩生物是一家主要从事临床阶段生物制药的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230093051953bca67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230093051953bca67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","09606","BK1161"],"gpt_icon":0},{"id":"2593492881","title":"每日卖空追踪 | 映恩生物-B 12月23日卖空量成交1.46万股，卖空比例为3.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593492881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593492881?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:30","pubTimestamp":1766478641,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月23日，跌0.67%，卖空量成交1.46万股，较上一交易日减少52.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163607a46e1a0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163607a46e1a0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","09606","HK0000252160.HKD","BK1161"],"gpt_icon":0},{"id":"2593494045","title":"映恩生物-B12月23日遭主力抛售763.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593494045","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593494045?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477753,"startTime":"0","endTime":"0","summary":"12月23日, 映恩生物-B股价跌0.67%，报收328.20元，成交金额1.5亿元，换手率0.49%，振幅6.36%，量比0.54。映恩生物-B今日主力资金净流出763.1万元，上一交易日主力净流出1627.9万元。该股近5个交易日上涨5.13%，主力资金累计净流出1363.4万元；近20日主力资金累计净流入576.5万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162104a46e07d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162104a46e07d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","09606","HK0000252152.HKD","BK1161","HK0000500386.USD","HK0000252160.HKD"],"gpt_icon":0},{"id":"2593494070","title":"HTI医药2025年12月第三周周报：行业高景气，持续关注创新药械产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2593494070","media":"海通国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593494070?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:07","pubTimestamp":1766477237,"startTime":"0","endTime":"0","summary":"2025年12月第三周A股医药板块表现与大盘相当。2025年12月第三周上证综指上涨0.03%，SW医药生物下跌0.1%，涨跌幅在申万一级行业中排名第19位。截至2025年12月19日，医药板块相对于全部A股的溢价水平目前处于正常水平，当前相对溢价率70.1%。2025年12月第三周美股标普医疗保健精选行业+0.6%，同期标普500+0.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223160731a6c4fe72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223160731a6c4fe72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02269","09606","01530","09939","02615","06078","HK0000252152.HKD","06160","HK0000500386.USD","BK1515","BK1574","HK0000252160.HKD","BK1161","02487","02359","01858","01801","LU2543165471.USD","06990","01276"],"gpt_icon":0},{"id":"2592579031","title":"每日卖空追踪 | 映恩生物-B 12月19日卖空量成交1.78万股，卖空比例为0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592579031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592579031?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133040,"startTime":"0","endTime":"0","summary":"映恩生物-B北京时间12月19日，涨9.29%，卖空量成交1.78万股，较上一交易日减少56.69%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163639a45f385a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163639a45f385a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","HK0000500386.USD","HK0000252160.HKD","09606","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"2592415714","title":"映恩生物-B12月19日主力净流入1207.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592415714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592415714?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132122,"startTime":"0","endTime":"0","summary":"12月19日, 映恩生物-B股价涨9.29%，报收336.60元，成交金额6.4亿元，换手率2.15%，振幅9.68%，量比3.03。映恩生物-B今日主力资金净流入1207.5万元，上一交易日主力净流出126万元。该股近5个交易日上涨3.19%，主力资金累计净流出683.4万元；近20日主力资金累计净流入3016.9万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161633a6b62e8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161633a6b62e8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","LU2543165471.USD","09606","BK1161","HK0000252152.HKD","HK0000500386.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":0.2179},{"period":"1month","weight":0.1571},{"period":"3month","weight":0.2246},{"period":"6month","weight":0.2543},{"period":"1year","weight":2.8161},{"period":"ytd","weight":0.2106}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"映恩生物是一家主要从事临床阶段生物制药的投资控股公司。该公司致力于为癌症和自身免疫性疾病等患者研发抗体偶联药物（ADC）创新药物。该公司的主要候选药物产品包括DB-1303/BNT323、DB-1311/BNT324、DB-1310、DB-1305/BNT325、DB-1419和DB-2304。该公司的产品主要用于靶向治疗子宫内膜癌（EC）、乳腺癌（BC）、小细胞肺癌（SCLC）、去势抵抗性前列腺癌（CRPC）、食管鳞状细胞癌（ESCC）及头颈部鳞状细胞癌（HNSCC）。该公司主要在国内和国外市场开展业务。","exchange":"SEHK","name":"映恩生物-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"映恩生物-B,09606,映恩生物-B股票,映恩生物-B股票老虎,映恩生物-B股票老虎国际,映恩生物-B行情,映恩生物-B股票行情,映恩生物-B股价,映恩生物-B股市,映恩生物-B股票价格,映恩生物-B股票交易,映恩生物-B股票购买,映恩生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"映恩生物-B(09606)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供映恩生物-B(09606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}